Loading
Latest filing published 22 Oct 2026 for HYPHENS PHARMA INTERNATIONAL LIMITED, €15k.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Lim See Wah in Hyphens Pharma International Limited. The record holds 12 filings, for trades running from 18 May 2018 to 21 October 2026.
Both buying and selling appear: 8 purchases worth €5.4M, against 1 sale. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 7 purchases and no sales.
The median purchase comes to €13k. Across 7 purchases, this insider has always bought alone, with no colleague buying within 30 days. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +7.5%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 22 October 2026, the filings show an open-market purchase worth €15k in Hyphens Pharma International Limited. Filings reach the SGX feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Source: insider filings from SGX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations